Tetrabenazine is a reversible inhibitor of the vesicular monoamine transporter type 2 (VMAT2), which depletes the storage of neurotransmitters such as dopamine, serotonin, and norepinephrine in the presynaptic neuron. This action is particularly beneficial in reducing involuntary movements associated with hyperkinetic disorders.